Immunomodulation by mesenchymal stem cells: a potential therapeutic strategy for type 1 diabetes - Test2 - elhamkhani - TriplyDB

Immunomodulation by mesenchymal stem cells: a potential therapeutic strategy for type 1 diabetes

Immunomodulation by mesenchymal stem cells: a potential therapeutic strategy for type 1 diabetes

http://www.wikidata.org/entity/Q24644691

about

Reversal of type 1 diabetes via islet β cell regeneration following immune modulation by cord blood-derived multipotent stem cells Human cord blood stem cell-modulated regulatory T lymphocytes reverse the autoimmune-caused type 1 diabetes in nonobese diabetic (NOD) mice Targeting improves MSC treatment of inflammatory bowel disease Cell therapies for pancreatic beta-cell replenishment Role of stem cells during diabetic liver injury Recent Trends in Therapeutic Approaches for Diabetes Management: A Comprehensive Update Stem cell therapy to cure type 1 diabetes: from hype to hope.Mesenchymal Stem Cells: Rising Concerns over Their Application in Treatment of Type One Diabetes Mellitus Concise review: pancreas regeneration: recent advances and perspectives Current stem cell based therapies in diabetes Cell adhesion and long-term survival of transplanted mesenchymal stem cells: a prerequisite for cell therapy Mesenchymal Stem Cells as Therapeutic Candidates for Halting the Progression of Diabetic Nephropathy Human mesenchymal stem cells suppress the stretch-induced inflammatory miR-155 and cytokines in bronchial epithelial cells Concise Review: Fat and Furious: Harnessing the Full Potential of Adipose-Derived Stromal Vascular Fraction The role of bone marrow derived-mesenchymal stem cells in attenuation of kidney function in rats with diabetic nephropathy.A new mesenchymal stem cell (MSC) paradigm: polarization into a pro-inflammatory MSC1 or an Immunosuppressive MSC2 phenotype.Recipient Glycemic Micro-environments Govern Therapeutic Effects of Mesenchymal Stem Cell Infusion on Osteopenia MSC-derived Extracellular Vesicles Attenuate Immune Responses in Two Autoimmune Murine Models: Type 1 Diabetes and Uveoretinitis.Mesenchymal stem cell-based treatment for microvascular and secondary complications of diabetes mellitus.The role of bone marrow mesenchymal stromal cell derivatives in skin wound healing in diabetic mice.The antidiabetic effect of MSCs is not impaired by insulin prophylaxis and is not improved by a second dose of cells.Mesenchymal stem cell therapy for nonhealing cutaneous wounds Under a nonadherent state, bone marrow mesenchymal stem cells can be efficiently induced into functional islet-like cell clusters to normalize hyperglycemia in mice: a control study Mesenchymal stem cells: paracrine signaling and differentiation during cutaneous wound repair Stem cell educator therapy and induction of immune balance.Human mesenchymal stem cells protect human islets from pro-inflammatory cytokines.Human Bone Marrow Derived Mesenchymal Stem Cells Regulate Leukocyte-Endothelial Interactions and Activation of Transcription Factor NF-Kappa B.Congenic mesenchymal stem cell therapy reverses hyperglycemia in experimental type 1 diabetes.Differentiation of human adipose-derived mesenchymal stem cell into insulin-producing cells: an in vitro study.Reduction of acute rejection by bone marrow mesenchymal stem cells during rat small bowel transplantation.Intravenous vs intraperitoneal mesenchymal stem cells administration: what is the best route for treating experimental colitis?Cooperation by fibroblasts and bone marrow-mesenchymal stem cells to improve pancreatic rat-to-mouse islet xenotransplantation Stem cell-derived islet cells for transplantation Transplantation of heterospheroids of islet cells and mesenchymal stem cells for effective angiogenesis and antiapoptosis.Adipose tissue-derived mesenchymal stem cells exert in vitro immunomodulatory and beta cell protective functions in streptozotocin-induced diabetic mice model.Macroporous three-dimensional PDMS scaffolds for extrahepatic islet transplantation.Stem cell approaches for diabetes: towards beta cell replacement.HCELL Expression on Murine MSC Licenses Pancreatotropism and Confers Durable Reversal of Autoimmune Diabetes in NOD Mice.Human embryonic stem cell-derived mesenchymal stromal cells.Mesenchymal stem cells enhance allogeneic islet engraftment in nonhuman primates.

P2860

Q21245299-1B1FA791-90D8-4735-B196-870B8C8E88D4 Q21562482-5E0A40F4-6B1E-4E6A-B392-3062A48359FF Q24601626-1DD446A4-01AC-4DF2-B7A0-DD441062EE5D Q26741240-7E32AD6E-6CEB-4DA4-88A8-14F73E0CF160 Q26773551-E9A785CC-F3F5-4152-9D7F-C2BD82CF619E Q26798145-34FF97BA-DD4A-40D3-A3E5-69F587D42C48 Q26823294-E809C828-1B4E-4FE7-93EC-A845C20B43BC Q26864580-05ECDCF2-209B-4011-8BA2-2F6B37F94B13 Q27013646-ACC58EF9-B0FF-4158-A742-267B605D0FFA Q28074914-AAEEDD74-0593-4B40-8D12-16F9149CA046 Q28082334-6B360BCE-906F-4F98-91EE-97919E83AF12 Q28354224-3AFABD0C-221A-49AC-AD2D-9CD6B68838E7 Q28535304-2EBC3780-17D1-4364-806E-15DE818BAC68 Q33553011-B014F96D-E86D-4645-9E51-A5E0FEDC746F Q33557060-A6BC6D3B-6757-41A6-B9EE-4256D1DB6509 Q33570359-A9F85AED-C96C-4D4C-BB5C-12F19CBE8A75 Q33588206-088B6A26-CF98-48B3-90C0-050DB9DE71F2 Q33659353-99D48AA5-0F47-4306-B228-0F3DA4892219 Q33719419-102BCA2B-6856-4595-A403-BE78483E5813 Q33778239-F55B693E-7816-480A-A335-BEE36EE6859F Q33815233-9CBD3213-02E6-48D9-B66E-08D3C0A4DF24 Q33825282-6C20BFAF-69A2-4CD4-B749-B1C29952C617 Q33827066-8CCDCB49-9AF6-4C03-A372-2A090FE2A0C0 Q33987579-1E038FE3-61A4-496E-B6B0-8965F874A988 Q34290347-4BD9DE99-36DB-4C18-88F5-7E4550E2A220 Q34292905-A2BF7C85-8C18-4E1C-80F0-26CEBD885418 Q34306920-0717A314-F5F7-4140-9700-84EB873605C5 Q34355278-B3E00C00-C9B8-4434-92BF-918FFD5E4188 Q34524274-5516EA10-9D1F-4F6C-8E2B-671CE29E1CEE Q34702762-974D6890-4836-4414-AA28-76DB310C556C Q34779125-DEA53935-D768-4CA4-81E0-4A5059A274E2 Q34979813-B1D39C39-F5FB-4C57-8F5C-51269C757DFD Q35156849-1904D485-FF74-42FB-BBE3-A19932DE3B47 Q35167245-C51BB1B8-3993-40AB-86B7-DE10D4918C76 Q35373250-D1B9E905-A0D9-44E8-97C3-ADEFE185320B Q35601055-CAEEEFC2-E6AB-40C2-8F94-E41C8FFE5699 Q35617374-D4F00FDE-0A13-4BB1-B31E-9D19967AF996 Q35660316-F54B03E7-B912-4A84-AD1A-77928A0F0D64 Q35681446-2D9C890C-98CA-4C4A-BA89-1BAA2DF277DD Q35757109-A3D55291-C389-4906-B7FA-0E6F635D90C9

P2860

Immunomodulation by mesenchymal stem cells: a potential therapeutic strategy for type 1 diabetes

http://www.wikidata.org/entity/Q24644691

description

2008 nî lūn-bûn

@nan

2008 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

name

Immunomodulation by mesenchyma ...... c strategy for type 1 diabetes

@ast

Immunomodulation by mesenchyma ...... c strategy for type 1 diabetes

@en

Immunomodulation by mesenchyma ...... c strategy for type 1 diabetes

@nl

type

label

Immunomodulation by mesenchyma ...... c strategy for type 1 diabetes

@ast

Immunomodulation by mesenchyma ...... c strategy for type 1 diabetes

@en

Immunomodulation by mesenchyma ...... c strategy for type 1 diabetes

@nl

prefLabel

Immunomodulation by mesenchyma ...... c strategy for type 1 diabetes

@ast

Immunomodulation by mesenchyma ...... c strategy for type 1 diabetes

@en

Immunomodulation by mesenchyma ...... c strategy for type 1 diabetes

@nl

P1433

Q24644691-17EB7351-B3BF-418B-87B1-DF5B5B3D941B

P1476

Q24644691-25E33EBF-E3F6-4354-B7D6-AC9532E32FF3

P2093

Q24644691-51DAA4D1-4A88-4942-A917-BCCDB92905EE

Q24644691-D79A104F-F48F-4C28-9B21-06D48469FF9A

Q24644691-F375A2A1-7981-4BC1-8B26-7C75BECE1E83

Q24644691-FC889EE5-F13C-4C28-8A66-FF6B5DFD86B0

P275

Q24644691-1637AB2B-0023-4E27-9B63-C2AA30A58977

P2860

Q24644691-0C5AC28F-FC2A-436A-9B4E-0335DBA5A44A

Q24644691-0F76238F-2ECD-4F55-9B1E-082863E77986

Q24644691-106915C6-88C5-44F4-AAD5-37826D7EE791

Q24644691-18B0D5D1-1451-4EB6-8F5A-7CF750C38A30

Q24644691-1B1534CF-254A-4C7E-96D8-A2ED3F8AB5A9

Q24644691-244170B7-2B6F-432A-8FCF-589AB76CA077

Q24644691-282228FB-7F3D-4D72-B792-6385ADEE9EA4

Q24644691-350D8625-7200-406C-A7D7-7C310906675E

Q24644691-38BDFC37-8D6B-43D7-BCA7-D699F0A87B7C

Q24644691-3C1BABE2-AB2A-4B15-8EB4-AB95A6EF80B6

P304

Q24644691-979B757B-780C-460C-870C-F41BABD8A343

P31

Q24644691-41137653-FCF5-42E6-B110-7127B05EB65E

Q24644691-497D77A0-94F6-4E06-87F3-A342DDDFD099

P3181

Q24644691-A7881200-0A18-4B9A-A1A8-45FE9EE51AC2

P356

Q24644691-A831B8B5-DA6D-4B92-BAE2-40EA2A6DAD84

P407

Q24644691-63EF2328-5EED-4C19-96A8-1BCECFE1232E

P433

Q24644691-36DD0E66-31A3-41E0-B9F1-CC24F7A50E41

P478

Q24644691-6D28666C-117E-46E3-8A73-66285CAA9736

P50

Q24644691-6BB50B7D-E414-4D5E-9F5E-A8F38B5A969A

P5008

Q24644691-74C7FF1A-0ADB-4780-BAEA-5BECBDCCA881

P577

Q24644691-018F0157-DD43-455B-9376-86FB130549E0

Q24644691-743373FC-8C29-402D-A1EE-46177CAD0854

P5875

Q24644691-588C13DD-F1BF-40C2-97C6-08C81C7D91CB

P698

Q24644691-A208FA5F-2D91-4367-A2AB-319388466E7E

P921

Q24644691-149414BC-0A76-41BA-AD4B-A63AFDDAD7EB

Q24644691-776DF146-F5F5-498A-9306-76B02985B3D6

Q24644691-A482FC66-B1EC-4320-B011-64D333B13AA0

P932

Q24644691-B7045DE9-BEBA-4B0D-8467-40FC4BEBC58E

P3181

P356

P1433

P1476

Immunomodulation by mesenchyma ...... c strategy for type 1 diabetes

@en

P2093

Chaker N Adra

http://www.w3.org/2001/XMLSchema#string

Mark Atkinson

http://www.w3.org/2001/XMLSchema#string

Mohamed H Sayegh

http://www.w3.org/2001/XMLSchema#string

Reza Abdi

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution-NonCommercial-NoDerivatives

P2860

Mesenchymal stem cells avoid allogeneic rejection

Multilineage potential of adult human mesenchymal stem cells

Cell therapy using allogeneic bone marrow mesenchymal stem cells prevents tissue damage in collagen-induced arthritis

Maintenance of the hematopoietic stem cell pool by CXCL12-CXCR4 chemokine signaling in bone marrow stromal cell niches

Mesenchymal stem cells reside in virtually all post-natal organs and tissues

Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells

Marrow stromal cells as stem cells for nonhematopoietic tissues

Mesenchymal stem cells

Human mesenchymal stem cells modulate B-cell functions

Concise review: mesenchymal stem cells: their phenotype, differentiation capacity, immunological features, and potential for homing.

P304

1759-67

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

122738

http://www.w3.org/2001/XMLSchema#string

P356

10.2337/DB08-0180

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

57

http://www.w3.org/2001/XMLSchema#string

P50

P5008

P577

2008-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5268854

http://www.w3.org/2001/XMLSchema#string

P698

18586907

http://www.w3.org/2001/XMLSchema#string

P921

type-1 diabetes

mesenchymal stem cells

P932

2453631

http://www.w3.org/2001/XMLSchema#string